Complement C3 is a novel plasma clot component with anti-fibrinolytic properties

Howes, Joanna-Marie; Richardson, Victoria R; Smith, Kerrie A; Schroeder, Verena; Somani, Riyaz; Shore, Anna; Hess, Katharina; Ajjan, Ramzi; Pease, Richard J; Keen, Jeffrey N; Standeven, Kristina F; Carter, Angela M (2012). Complement C3 is a novel plasma clot component with anti-fibrinolytic properties. Diabetes & vascular disease research, 9(3), pp. 216-225. London: Sage 10.1177/1479164111432788

Full text not available from this repository. (Request a copy)

Increased plasma clot density and prolonged lysis times are associated with cardiovascular disease. In this study, we employed a functional proteomics approach to identify novel clot components which may influence clot phenotypes.

Item Type:

Journal Article (Original Article)

Division/Institute:

04 Faculty of Medicine > Department of Haematology, Oncology, Infectious Diseases, Laboratory Medicine and Hospital Pharmacy (DOLS) > Clinic of Haematology and Central Haematological Laboratory

UniBE Contributor:

Schröder, Verena

ISSN:

1479-1641

Publisher:

Sage

Language:

English

Submitter:

Factscience Import

Date Deposited:

04 Oct 2013 14:35

Last Modified:

07 Jan 2020 13:44

Publisher DOI:

10.1177/1479164111432788

PubMed ID:

22253322

Web of Science ID:

000306940800007

URI:

https://boris.unibe.ch/id/eprint/13832 (FactScience: 220498)

Actions (login required)

Edit item Edit item
Provide Feedback